Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study | SpringerLink
Anticoagulation for Mechanical Heart Valves | Arteriosclerosis, Thrombosis, and Vascular Biology
Anticoagulation for mechanical (A) and bioprosthetic (B) heart valves.... | Download Scientific Diagram
Antithrombotic Therapy in Patients With Valvular Heart Disease
Warfarin in patients with mechanical heart valves | The BMJ
Antithrombotic Therapy in Patients With Valvular Heart Disease
Prosthetic Heart Valve Thrombosis | Journal of the American College of Cardiology
Risk of death and stroke associated with anticoagulation therapy after mitral valve repair | Heart
Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement - ScienceDirect
Mechanical Aortic Valve Replacement in Young Women Planning on Pregnancy: Maternal and Fetal Outcomes Under Low Oral Anticoagulation, a Pilot Observational Study on a Comprehensive Pre-Operative Counseling Protocol | Journal of the
Comments on the 2021 ESC/EACTS guidelines for the management of valvular heart disease | Revista Española de Cardiología
Nonusefulness of Antithrombotic Therapy After Surgical Bioprosthetic Aortic Valve Replacement - American Journal of Cardiology
After valve replacement
2021 ESC/EACTS Guidelines for the management of valvular heart disease - EuroIntervention
Anticoagulation Therapy Following Embolic or Hemorrhagic Stroke in the Patient with a Mechanical Heart Valve | Semantic Scholar
Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement - ScienceDirect
Biological Surgical Options in Young Patients for the Treatment of Severe Aortic Stenosis: Is the Jury Still Out? A Review
Journal of the Association of Physicians of India - JAPI
Anticoagulation Strategies After Bioprosthetic Valve Replacement: What Should We Do? - American College of Cardiology
Summary of Anticoagulation / Antiplatelet therapy for ... | GrepMed
Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence
Table 1 from Anticoagulation After Heart Valve Replacement or Transcatheter Valve Implantation. | Semantic Scholar
Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician. - Abstract - Europe PMC
Alfonso Valle on Twitter: "💡Bioprosthetic SAVR or mitral valve replacement ➡️Anticoagulation with VKA to an INR of 2.5 is reasonable for 3-6 months postoperatively (Class 2b) 💡On-X AVR ➡️ INR of 1.5-2.0, starting
JCM | Free Full-Text | The Efficacy and Safety of Direct Oral Anticoagulants versus Standard of Care in Patients without an Indication of Anti-Coagulants after Transcatheter Aortic Valve Replacement: A Meta-Analysis of